EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 257 filers reported holding EDITAS MEDICINE INC in Q1 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,288,153 | -83.8% | 918,234 | -74.3% | 0.00% | -100.0% |
Q1 2024 | $26,470,586 | +3.3% | 3,567,464 | +41.1% | 0.00% | 0.0% |
Q4 2023 | $25,619,476 | +146.1% | 2,529,070 | +89.5% | 0.00% | 0.0% |
Q3 2023 | $10,410,635 | -25.8% | 1,334,697 | -21.7% | 0.00% | 0.0% |
Q2 2023 | $14,031,803 | +120.8% | 1,704,958 | +94.5% | 0.00% | 0.0% |
Q1 2023 | $6,354,170 | -18.9% | 876,437 | -0.8% | 0.00% | 0.0% |
Q4 2022 | $7,834,958 | -29.3% | 883,310 | -2.5% | 0.00% | -50.0% |
Q3 2022 | $11,086,000 | -12.4% | 905,736 | -15.4% | 0.00% | 0.0% |
Q2 2022 | $12,662,000 | -40.7% | 1,070,453 | -4.6% | 0.00% | -33.3% |
Q1 2022 | $21,336,000 | -16.9% | 1,121,770 | +16.0% | 0.00% | 0.0% |
Q4 2021 | $25,665,000 | -31.6% | 966,698 | +5.9% | 0.00% | -40.0% |
Q3 2021 | $37,510,000 | -18.2% | 913,048 | +12.8% | 0.01% | -16.7% |
Q2 2021 | $45,849,000 | +13.0% | 809,459 | -16.2% | 0.01% | 0.0% |
Q1 2021 | $40,586,000 | -30.6% | 966,297 | +15.8% | 0.01% | -33.3% |
Q4 2020 | $58,504,000 | +93.6% | 834,453 | -22.5% | 0.01% | +50.0% |
Q3 2020 | $30,223,000 | +3.1% | 1,077,119 | +8.7% | 0.01% | 0.0% |
Q2 2020 | $29,311,000 | +93.5% | 990,890 | +29.7% | 0.01% | +50.0% |
Q1 2020 | $15,146,000 | -54.7% | 763,822 | -32.4% | 0.00% | -50.0% |
Q4 2019 | $33,447,000 | +40.7% | 1,129,544 | +8.1% | 0.01% | +33.3% |
Q3 2019 | $23,766,000 | +13.1% | 1,045,078 | +23.0% | 0.01% | 0.0% |
Q2 2019 | $21,022,000 | -54.2% | 849,732 | -54.7% | 0.01% | -53.8% |
Q1 2019 | $45,909,000 | +6.4% | 1,877,685 | -1.0% | 0.01% | 0.0% |
Q4 2018 | $43,161,000 | -21.7% | 1,897,163 | +9.5% | 0.01% | -7.1% |
Q3 2018 | $55,111,000 | -25.7% | 1,731,968 | -16.3% | 0.01% | -30.0% |
Q2 2018 | $74,142,000 | +18.8% | 2,069,280 | +9.9% | 0.02% | +17.6% |
Q1 2018 | $62,431,000 | +226.6% | 1,883,262 | +202.8% | 0.02% | +240.0% |
Q4 2017 | $19,114,000 | +41.4% | 622,019 | +10.5% | 0.01% | +25.0% |
Q3 2017 | $13,516,000 | +74.4% | 562,936 | +21.9% | 0.00% | +100.0% |
Q2 2017 | $7,748,000 | -43.8% | 461,700 | -25.3% | 0.00% | 0.0% |
Q1 2017 | $13,790,000 | +103.9% | 617,818 | +48.3% | 0.00% | +100.0% |
Q4 2016 | $6,762,000 | +98.8% | 416,648 | +65.1% | 0.00% | 0.0% |
Q3 2016 | $3,402,000 | -53.3% | 252,351 | -15.4% | 0.00% | -66.7% |
Q2 2016 | $7,282,000 | +47.7% | 298,460 | +109.1% | 0.00% | +50.0% |
Q1 2016 | $4,931,000 | – | 142,754 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wildcat Capital Management, LLC | 185,668 | $5,908,000 | 4.56% |
ARK Investment Management | 2,793,854 | $88,900,000 | 2.69% |
Elmwood Wealth Management, Inc. | 94,067 | $2,993,212,000 | 2.48% |
JS Capital Management LLC | 218,935 | $6,967,000 | 1.92% |
Casdin Capital, LLC | 460,000 | $14,637,000 | 1.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,158,841 | $36,874,000 | 1.32% |
Valiant Capital Management, L.P. | 379,800 | $12,085,000 | 1.07% |
Castle Rock Wealth Management, LLC | 16,315 | $442,000 | 0.70% |
Capital Impact Advisors, LLC | 57,406 | $1,861,000 | 0.64% |
Global Thematic Partners, LLC | 481,568 | $15,323,000 | 0.60% |